Journal
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
Volume 32, Issue 3, Pages 277-284Publisher
KLUWER ACADEMIC/PLENUM PUBL
DOI: 10.1023/A:1005541114029
Keywords
NM23; PuF; transcription; c-MYC; nuclease-hypersensitive; PDGF; differentiation
Categories
Funding
- NCI NIH HHS [CA66430, CA76496, CA83237] Funding Source: Medline
- NHLBI NIH HHS [T32-HL07343] Funding Source: Medline
- NIDDK NIH HHS [DK45518] Funding Source: Medline
Ask authors/readers for more resources
NM23-H2/NDP kinase B has been identified as a sequence-specific DNA-binding protein with affinity for a nuclease-hypersensitive element of the c-MYC gene promoter (Postel et al, 1993). The ability of Nm23-H2 to activate c-MYC transcription in vitro and in vivo via the same element demonstrates the biological significance of this interaction. Mutational analyses have identified Arg34, Asn69 and Lys135 as critical for DNA binding, but not required for the NDP kinase reaction. However, the catalytically important His118 residue is dispensible for sequence-specific DNA binding, suggesting that sequence-specific DNA recognition and phosphoryl transfer are independent properties. Nm23-H2 also has an activity that cleaves DNA site-specifically, involving a covalent protein-DNA complex. In a DNA sequence-dependent manner, Nm23-H2 recognizes additional target genes for activation, including myeloperoxidase, CD11b, and CCR5, all involved in myeloid-specific differentiation. Moreover, both NM23-H1 and Nm23-H2 bind to nuclease hypersensitive elements in the platelet-derived growth factor PDGF-A gene promoter sequence-specifically, correlating with either positive or negative transcriptional regulation. These data support a model in which NM23/NDP kinase modulates gene expression through DNA binding and subsequent structural transactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available